10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Costs of illness and care in Parkinson's disease: an evaluation in six countries.

      European Neuropsychopharmacology
      Ambulatory Care, economics, Antiparkinson Agents, therapeutic use, Cost of Illness, Europe, Female, Health Care Costs, statistics & numerical data, Hospitalization, Humans, Long-Term Care, Male, Parkinson Disease, drug therapy, Questionnaires

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We investigated the costs of Parkinson's Disease (PD) in 486 patients based on a survey conducted in six countries. Economic data were collected over a 6-month period and presented from the societal perspective. The total mean costs per patient ranged from EUR 2620 to EUR 9820. Direct costs totalled about 60% to 70% and indirect costs about 30% to 40% of total costs. The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences. However, inpatient care, long-term care and medication were identified as the major expenditures in the investigated countries. Copyright © 2010 Elsevier B.V. and ECNP. All rights reserved.

          Related collections

          Author and article information

          Comments

          Comment on this article